Related references
Note: Only part of the references are listed.Disadvantages of peginterferon and ribavirin treatment in older patients with chronic hepatitis C: an analysis using the propensity score
Hirotoshi Ebinuma et al.
HEPATOLOGY INTERNATIONAL (2012)
Evaluation of Phosphatidylinositol-4-Kinase IIIα as a Hepatitis C Virus Drug Target
Frederic H. Vaillancourt et al.
JOURNAL OF VIROLOGY (2012)
Hepatitis C virus production requires apolipoprotein A-I and affects its association with nascent low-density lipoproteins
Carmine Mancone et al.
GUT (2011)
Nicotinic acid induces apolipoprotein A-I gene expression in HepG2 and Caco-2 cell lines
Michael J. Haas et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Identification by Differential Tissue Proteome Analysis of Talin-1 as a Novel Molecular Marker of Progression of Hepatocellular Carcinoma
Hideaki Kanamori et al.
ONCOLOGY (2011)
Prediction of Effect of Pegylated Interferon Alpha-2b plus Ribavirin Combination Therapy in Patients with Chronic Hepatitis C Infection
Tetsuro Takayama et al.
PLOS ONE (2011)
MicroRNAs in Hepatobiliary and Pancreatic Cancers
Yoshimasa Saito et al.
Frontiers in Genetics (2011)
DNMT1 and DNMT3b silencing sensitizes human hepatoma cells to TRAIL-mediated apoptosis via up-regulation of TRAIL-R2/DR5 and caspase-8
Satoshi Kurita et al.
CANCER SCIENCE (2010)
Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
Takashi Watanabe et al.
CANCER SCIENCE (2010)
Polo-Like Kinase 1 Is Involved in Hepatitis C Virus Replication by Hyperphosphorylating NS5A
Yung-Chia Chen et al.
JOURNAL OF VIROLOGY (2010)
Effects of osteopontin inhibition on radiosensitivity of MDA-MB-231 breast cancer cells
Antje Hahnel et al.
RADIATION ONCOLOGY (2010)
MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells
Francesca Fornari et al.
CANCER RESEARCH (2009)
Architectural roles of multiple chromatin insulators at the human apolipoprotein gene cluster
Tsuyoshi Mishiro et al.
EMBO JOURNAL (2009)
Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy
Magdalena Sarasin-Filipowicz et al.
NATURE MEDICINE (2009)
Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties
C. Coulouarn et al.
ONCOGENE (2009)
Essential Role of Cyclophilin A for Hepatitis C Virus Replication and Virus Production and Possible Link to Polyprotein Cleavage Kinetics
Artur Kaul et al.
PLOS PATHOGENS (2009)
Cancer epigenetics: Modifications, screening, and therapy
Einav Nili Gal-Yam et al.
ANNUAL REVIEW OF MEDICINE (2008)
Possible molecular mechanism of the relationship between NS5B polymorphisms and early clearance of hepatitis C virus during interferon plus ribavirin treatment
Mitsuyasu Nakamura et al.
JOURNAL OF MEDICAL VIROLOGY (2008)
MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death
R. Schickel et al.
ONCOGENE (2008)
Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma
Yen-Shen Lu et al.
HEPATOLOGY (2007)
Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90
Toru Okamoto et al.
EMBO JOURNAL (2006)
Different anti-HCV profiles of statins and their potential for combination therapy with interferon
Masanori Ikeda et al.
HEPATOLOGY (2006)
Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells
Yoshimasa Saito et al.
CANCER CELL (2006)
Suppression of adiponectin gene expression by histone deacetylase inhibitor valproic acid
LP Qiao et al.
ENDOCRINOLOGY (2006)
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
C Esau et al.
CELL METABOLISM (2006)
Epigenetic therapy of cancer: past, present and future
CB Yoo et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B
I Hamamoto et al.
JOURNAL OF VIROLOGY (2005)
Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA
CL Jopling et al.
SCIENCE (2005)
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
T Wakita et al.
NATURE MEDICINE (2005)
Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system
M Ikeda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C
M Naito et al.
JOURNAL OF GASTROENTEROLOGY (2005)
Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas
H Duan et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft
L Gao et al.
JOURNAL OF VIROLOGY (2004)
Genetic polymorphims in promoter region of osteopontin gene may be a marker reflecting hepatitis activity in chronic hepatitis C patients
S Mochida et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome
GN Liang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin
LM Butler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Medical progress: Hepatitis C virus infection.
GM Lauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Reduction of telomerase activity in human liver cancer cells by a histone deacetylase inhibitor
M Nakamura et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2001)
Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity
S Ashkar et al.
SCIENCE (2000)
Share Paper
